GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Amniotics AB (OSTO:AMNI) » Definitions » Price-to-Free-Cash-Flow

Amniotics AB (OSTO:AMNI) Price-to-Free-Cash-Flow : N/A (As of Jun. 14, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Amniotics AB Price-to-Free-Cash-Flow?

As of today (2024-06-14), Amniotics AB's share price is kr0.0042. Amniotics AB's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was kr-0.10. Hence, Amniotics AB's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Amniotics AB's Price-to-Free-Cash-Flow or its related term are showing as below:

During the past 5 years, Amniotics AB's highest Price-to-Free-Cash-Flow Ratio was 5.95. The lowest was 0.00. And the median was 0.00.

OSTO:AMNI's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 31.085
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Amniotics AB's Free Cash Flow per Share for the three months ended in Dec. 2023 was kr0.00. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was kr-0.10.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 70.10% per year.

During the past 5 years, Amniotics AB's highest 3-Year average Free Cash Flow per Share Growth Rate was 70.10% per year. The lowest was 70.10% per year. And the median was 70.10% per year.


Amniotics AB Price-to-Free-Cash-Flow Historical Data

The historical data trend for Amniotics AB's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amniotics AB Price-to-Free-Cash-Flow Chart

Amniotics AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
- - - - -

Amniotics AB Quarterly Data
Dec19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Amniotics AB's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, Amniotics AB's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Amniotics AB's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Amniotics AB's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Amniotics AB's Price-to-Free-Cash-Flow falls into.



Amniotics AB Price-to-Free-Cash-Flow Calculation

Amniotics AB's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.0042/-0.104
=N/A

Amniotics AB's Share Price of today is kr0.0042.
Amniotics AB's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.10.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Amniotics AB  (OSTO:AMNI) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Amniotics AB Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Amniotics AB's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Amniotics AB (OSTO:AMNI) Business Description

Traded in Other Exchanges
Address
Scheelevagen 2, Lund, SWE, 223 63
Amniotics AB is a biopharma company focusing on mesenchymal stem cells from amniotic fluid. It provides a novel platform for the production of medically superior mesenchymal stem cells including ethical and medically sound bio-banking opportunities for the newborn.

Amniotics AB (OSTO:AMNI) Headlines

From GuruFocus

American Noble Gas Announces Ticker Symbol Change

By Stock market mentor Stock market mentor 01-23-2023